A well-funded pharma foe is back for campaign 2020
Patients for Affordable Drugs Now, the drug pricing advocacy group backed by the billionaire activists Laura and John Arnold, announced its first 2020 target today: Sen. Thom Tillis (R-N.C.), a longtime pharmaceutical industry ally.
In a seven-figure ad barrage, the group will cast Tillis as "uniquely bad on the issue of drug prices," citing his history of accepting major campaign funding from drug industry PACs, authoring legislation to help drug companies protect their intellectual property, and his opposition to bipartisan drug pricing legislation in the Senate.
The radio, digital, and TV ads will, of course, also feature a patient voice speaking out against Tillis: that of Steven Hadfield, a Tar Heel whose cancer drugs run him $132,000 each year.
In a seven-figure ad barrage, the group will cast Tillis as "uniquely bad on the issue of drug prices," citing his history of accepting major campaign funding from drug industry PACs, authoring legislation to help drug companies protect their intellectual property, and his opposition to bipartisan drug pricing legislation in the Senate.
The radio, digital, and TV ads will, of course, also feature a patient voice speaking out against Tillis: that of Steven Hadfield, a Tar Heel whose cancer drugs run him $132,000 each year.
.png)
No hay comentarios:
Publicar un comentario